Crossmark

Anti-COVID property of subcutaneous ivermectin in synergy with zinc among midlife moderately symptomatic patients: a structured summary of a study protocol for a randomised controlled trial

Crossref DOI link: https://doi.org/10.1186/s13063-021-05487-z

Published Online: 2021-09-06

Published Print: 2021-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Ashraf, Shoaib https://orcid.org/0000-0002-1218-4877
Ashraf, Sohaib https://orcid.org/0000-0003-3127-3557
Farooq, Iqra https://orcid.org/0000-0002-9832-9589
Ashraf, Sidra https://orcid.org/0000-0002-4254-2583
Ashraf, Moneeb https://orcid.org/0000-0002-5769-9524
Imran, Muhammad Ahmad https://orcid.org/0000-0003-3358-229X
Kalsoom, Larab https://orcid.org/0000-0003-1075-6285
Akmal, Rutaba

Ghufran, Muhammad

Rafique, Sundas

Akram, Muhammad Kiwan https://orcid.org/0000-0002-8415-9363
Habib, Zaigham

Siddiqui, Uzma Nasim

Ahmad, Ammara

Arshad, Shahroze

Virk, Muhammad Abdul Rehman

Gul, Mehak

Awais, Abeer bin

Hassan, Muhammad

Sherazi, Syed Sami Hussain https://orcid.org/0000-0002-8703-6342
Safdar, Zartasha https://orcid.org/0000-0002-0837-8812
Munir, Isra

Khalid, Hamna

Munir, Khalid

Majeed, Nighat

Alahmadi, Yaser Masuod

Humayun, Ayesha

Saboor, Qazi Abdul

Ahmad, Ali

Ashraf, Muhammad

Izhar, Mateen

,

Hilal, Abubakr

Muhammad, Arz

Shaukat, Zeeshan

Ahmad, Sohail

Hayat, Kanwal

Amjad, Ghazala

Kousar, Misbah

Hafsa, Hadiqa Tul

Choudhary, Zawar Ahmad

Hafeez, Umair

Mughal, Tayyab

Khalid, Noman

Iqbal, Qurat-ul-Ain

Umer, Roa

Muzafar, Tayyaba

Zulfiqar, Sibgha

Alam, Saadia Shahzad

Sarfraz, Saulat

Anwar, Muhammad Imran

Malik, Amber

Mahmud, Talha

Akmal, Adeen

Nadeem, Muhammad Faisal

Matti, Nazish

Azam, Muhammad

Majeed, Nighat

Arshad, Ali

Nawaz, Khawar

Yousaf, Muhammad Ismail Khalid

Baig, Aadil Maqsood Atif Amin

Bilal, Muhammad

Zahid, Muhammad Nauman
Funding

Funding for this research was provided by:

smile welfare organization
License Information

Text and Data Mining valid from 2021-09-06

Version of Record valid from 2021-09-06
More Information

Article History

Received: 23 July 2021

Accepted: 26 July 2021

First Online: 6 September 2021

Declarations

:

: Ethics Committee of Shaikh Zayed Post-Graduate Medical Complex, Lahore, Pakistan has approved the study on July 14<sup>th</sup>, 2020 with ID SZMC/IRB/Internal0056/2020. I certify that this trial has received ethical approval from the appropriate ethical committee as described above. Prior to enrolment, participants will be fully informed of the study and asked to sign the consent form in order to be eligible for randomization and participation.

: Not applicable

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below